Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03276468
Brief Title: Evaluation of Atezolizumab-Venetoclax-Obinutuzumab Combination in Relapse/Refractory Lymphomas

First Submitted : September 7, 2017
First Submitted that Met QC Criteria : September 7, 2017
First Posted : September 8, 2017

Last Update Submitted that Met QC Criteria : October 9, 2018
Last Update Posted : October 10, 2018